Tech Daily Dominican Republic: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Dominican Republic.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 9, 2026

Jan. 9, 2026

ACTG Launches IPACE-HIV to Study Frailty Intervention

GlobeNewswire

Jan. 9, 2026

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

GlobeNewswire

Jan. 9, 2026

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint

GlobeNewswire

Jan. 9, 2026

Nutanix to Present at Upcoming Investor Conference

GlobeNewswire

Jan. 9, 2026

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

GlobeNewswire

Jan. 9, 2026

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 9, 2026

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”

GlobeNewswire

Jan. 9, 2026

Clene Announces Registered Direct Offering of Over $28 Million

GlobeNewswire

Jan. 9, 2026

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

GlobeNewswire

Jan. 9, 2026

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook

GlobeNewswire

Jan. 9, 2026

Vocodia Holdings Corp. (OTC: VHAI) Targets "Shadow AI" with Acquisition of PrivacyPal.ai; Introduces Solution to the "Fidelity Paradox"

GlobeNewswire

Jan. 9, 2026

Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor

GlobeNewswire

Jan. 9, 2026

iAltA Holdings Acquires BridgeFT

GlobeNewswire

Jan. 9, 2026

ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT

GlobeNewswire

Jan. 9, 2026

NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

GlobeNewswire

Jan. 9, 2026

NordPass launches Authenticator for personal accounts

GlobeNewswire

Jan. 9, 2026

Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones

GlobeNewswire

Jan. 9, 2026

Global Mofy Announces Fiscal Year 2025 Financial Results; Conference Call Scheduled for Friday, January 9th, at 8:30 AM Eastern Time

GlobeNewswire

Jan. 9, 2026

Peer-reviewed study demonstrates LEON’s FR-JET® modular mixer enables stable high-concentration mRNA-LNPs with enhanced in vivo activity

GlobeNewswire

Jan. 9, 2026

Bruder Consulting & Venture Group to become Dark Horse Consulting Regenerative Medicine

GlobeNewswire